{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-001253","form_type":"8-K","ticker":"BGMS","cik":"0001130166","company_name":"Bio Green Med Solution, Inc.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.000660+00:00","generated_at":"2026-05-26T01:01:38.046842+00:00","sec_items":["1.01","5.02","3.01","3.03","5.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Cyclacel changes control; new majority owner holds 70% and appoints new CEO and CFO","bullets":["Datuk Dr. Doris Wong Sing Ee bought 1M Series C and 1.745M Series D shares from ex-interim CEO David Lazar for $6.3M, gaining 70% ownership.","Preferred shares converted into 194.63M common shares, making Wong the controlling shareholder.","David Lazar resigned as interim CEO; Datuk Dr. Doris Wong Sing Ee appointed CEO and director; Kiu Cu Seng appointed CFO, executive director, secretary.","Five directors resigned, including Samuel Barker, Paul McBarron, Spiro Rombotis; new independent director Chong Kwang Fock appointed.","Nasdaq compliance regained for equity rule; company subject to one-year Mandatory Panel Monitor."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-001253","json":"https://secwatch.observer/filing/0001829126-25-001253.json","markdown":"https://secwatch.observer/filing/0001829126-25-001253.md","text":"https://secwatch.observer/filing/0001829126-25-001253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/0001829126-25-001253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/cyclacel_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T01:01:38.046842+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"58cd8d0679","claim":"David Lazar resigned as Interim Chief Executive Officer at Bio Green Med Solution, Inc..","evidence_excerpt":"David Lazar, the Company’s interim Chief Executive Officer, interim principal financial officer, interim principal accounting officer, and Secretary, provided notice of his resignation as Chief Executive Officer and Secretary of the Company effective February 26, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/0001829126-25-001253-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Interim Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"721a8d5b54","claim":"Datuk Dr. Doris Wong Sing Ee was elected as Director at Bio Green Med Solution, Inc..","evidence_excerpt":"Datuk Dr. Doris Wong Sing Ee was also elected to the Board of the Company as of the effective date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/0001829126-25-001253-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"92b7af4b5f","claim":"Datuk Dr. Doris Wong Sing Ee was appointed as Chief Executive Officer at Bio Green Med Solution, Inc..","evidence_excerpt":"the Board appointed Datuk Dr. Doris Wong Sing Ee, as Chief Executive Officer and, in such role, she will serve as the Company’s principal executive officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1130166/000182912625001253/0001829126-25-001253-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}